Exogenous SLFN12 reduces in vivo TNBC proliferation and invasion, increases luminal markers and a gene signature that reducts better breast cancer survival in cohort database analysis
Ontology highlight
ABSTRACT: Our results suggest that increased SLFN12 expression modulates TNBC aggressiveness through a gene signature which could offer new targets for treatment.
ORGANISM(S): Homo sapiens
PROVIDER: GSE215442 | GEO | 2023/01/25
REPOSITORIES: GEO
ACCESS DATA